Adc therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Adc therapeutics Contact Number

Contact Us – ADC Therapeutics

Just Now Adctherapeutics.com Show details

For partnership inquiries, please contact: [email protected]adctherapeutics.com. For investor inquiries, please contact: Amanda Hamilton, ADC Therapeutics [email protected]adctherapeutics.com. For EU media inquiries, please contact: Alexandre Müller, Dynamics Group [email protected] For USA media inquiries, please contact: Annie Starr, 6 Degrees

Category: Contact SupportShow more

Resources Contact – ADC Therapeutics

1 hours ago Ir.adctherapeutics.com Show details

917-288-7023

Amanda Hamilton. +1 917-288-7023. Send Email. The following errors must be corrected. First Name is required. Last Name is required. Company Name is required. Email Address is required. Phone Number is …

Category: Contact SupportShow more

ADC Therapeutics ADVANCING Patient Support Site for

Just Now Advancingpatientsupport.com Show details

855-690-0340

Contact ADVANCING Patient Support. Phone: 1-855-690-0340 Fax: Please save 1-855-690-0340 in your contacts so you recognize the number. ADC Therapeutics does not necessarily endorse the organization associated with this link and takes no responsibility for the content contained therein. This resource link is for informational purposes only.

Category: Support NumberShow more

ADC Therapeutics Antibody Drug Conjugates Cancer Treatment

2 hours ago Adctherapeutics.com Show details

ADC Therapeutics is advancing novel PBD-based antibody drug conjugates through clinical development to improve patient outcomes in multiple oncology indications. Explore the Pipeline. innovation. Proprietary PBD-based technology is the foundation for a robust pipeline of ADCs in the treatment of hematologic cancers and solid tumors.

Category: Contact NumberShow more

ADC Therapeutics Crunchbase Company Profile & Funding

6 hours ago Crunchbase.com Show details

908-731-5556

Company Type For Profit. Contact Email [email protected]adctherapeutics.com. Phone Number +1 908-731-5556. ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors.

Founder: Christopher Martin
Location: Lausanne, Vaud
Founded: Jan 01, 2011

Category: Contact NumberShow more

ADC Therapeutics SA Company Profile Epalinges, VAUD

3 hours ago Dnb.com Show details

ADC Therapeutics SA is located in Epalinges, VAUD, Switzerland and is part of the Pharmaceutical and Medicine Manufacturing Industry. ADC Therapeutics SA has 208 employees at this location and generates $54.68 million in sales (USD). (Sales figure is modelled). There are 2 companies in the ADC Therapeutics SA corporate family.

Category: Contact NumberShow more

Resources & Inquiries – ADC Therapeutics

2 hours ago Adctherapeutics.com Show details

ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors September 27, 2021 ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference September 23, 2021

Category: Contact NumberShow more

ADC Therapeutics Company Profile Office Locations

3 hours ago Craft.co Show details

ADC Therapeutics has 116 employees across 4 locations. See insights on ADC Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and …

Category: Contact NumberShow more

ADC Therapeutics Email Format adctherapeutics.com Emails

9 hours ago Rocketreach.co Show details

ADC Therapeutics Email Format. ADC Therapeutics uses 1 email formats, with first '.' last (ex. [email protected]) being used 100.0% of the time. Get Verified Emails for ADC Therapeutics Employees. ADC Therapeutics's Email Format. Percentage.

Category: Contact NumberShow more

ADC Therapeutics SA (Form: F1, Received: 04/24/2020 17:25:24)

1 hours ago Content.edgar-online.com Show details

(908) 546-5556

ADC Therapeutics America, Inc. 430 Mountain Avenue, 4th Floor Murray Hill, NJ 07974 (908) 546-5556 (Name, address, including zip code, and telephone number, including area code, of agent for service)

Category: Contact NumberShow more

ADVANCING Patient Support Site for ADC Therapeutics

4 hours ago Advancingpatientsupport.com Show details

855-690-0340

Have them save 1-855-690-0340 in their contacts so they recognize the number. ADVANCING Patient Support is a patient support program from ADC Therapeutics. For more information or support, contact ADVANCING Patient Support at 1-855-690-0340.

Category: Support NumberShow more

Medical Information Hub ADC Therapeutics HCP Site

8 hours ago Adctmedical.com Show details

855-690-0340

Contact ADC Therapeutics Submit a Medical Inquiry Reach out to the ADC Therapeutics team with your specific medical inquiry. Contact Medical Affairs 1-855-690-0340 8:00 AM to 6:00 PM ET

Category: Contact NumberShow more

Our Leadership Team – ADC Therapeutics

2 hours ago Adctherapeutics.com Show details

ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors September 27, 2021 ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference September 23, 2021

Category: Contact NumberShow more

Careers – ADC Therapeutics

Just Now Adctherapeutics.com Show details

The Human Resources team manages the recruiting for all positions at ADC Therapeutics. We will only accept résumés from a search agency/recruiter if we have a signed agreement in place and we have formally requested your help on a specific role. Unsolicited résumés sent to ADCT will be considered property of ADCT.

Category: Contact NumberShow more

ADCT ADC Therapeutics SA • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

ADCT-901 targets KAAG1, a novel tumor target for ADC development. ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates (ADCs) for patients with hematologic malignancies and solid tumors, today announced the first patient has been dosed in the Phase 1 …

Category: Contact NumberShow more

Stephen EvansFreke, Our Board of Directors ADC Therapeutics

2 hours ago Adctherapeutics.com Show details

Stephen Evans-Freke is a Non-Executive Director on the Board of ADC Therapeutics, as well as Co-Founder and Managing General Partner of Auven Therapeutics. Mr. Evans-Freke has been associated with the biotechnology industry for over 35 years as an investment banker, asset manager, entrepreneur, company CEO, and venture capitalist.

Category: Contact NumberShow more

Privacy Policy – ADC Therapeutics

7 hours ago Adctherapeutics.com Show details

The protection of your personal data is important to ADC Therapeutics SA, at Biopôle, Route de la Corniche 3b, 1066 Epalinges, Switzerland (“ADCT”). Please be sure you (“You”) have read this entire Policy before using the Website.

Category: Contact NumberShow more

FDA Approved AntibodyDrug Conjugates Up To 2021

2 hours ago Biochempeg.com Show details

Category: Contact NumberShow more

Investor Relations & Latest News – ADC Therapeutics

2 hours ago Ir.adctherapeutics.com Show details

Latest news for ADC Therapeutics, a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation ADCs

Category: Contact NumberShow more

ADC Therapeutics SA (ADCT) Company Profile & Facts Yahoo

4 hours ago Finance.yahoo.com Show details

See the company profile for ADC Therapeutics SA (ADCT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Contact NumberShow more

For injection, for intravenous use SUBMIT COMPLETED

6 hours ago Advancingpatientsupport.com Show details

ADC Therapeutics is authorized to contact me about the information provided on this form and as needed to facilitate my patient’s enrollment and participation in the Program; (5)I have read and understand the Terms and Conditions of the Copay Assistance Program available from

Category: Contact NumberShow more

ADC Therapeutics Appoints Joseph Camardo, MD, as Head of

6 hours ago Ir.adctherapeutics.com Show details

917 288 7023

ADC Therapeutics Contacts. Investors Contact Amanda Hamilton ADC Therapeutics [email protected] Tel.: +1 917 288 7023. EU Media Contact Alexandre Müller Dynamics Group [email protected] Tel: +41 (0) 43 268 3231. USA Media Contact Annie Starr

Category: Contact NumberShow more

ADC Therapeutics and Adagene Announce License Agreement

1 hours ago Ir.adctherapeutics.com Show details

21 653 0200

The company has raised over $85 million through its series A to C financing. ADC Therapeutics Contacts. Investors Contact. Dr. Chris Martin. Chief Executive Officer. [email protected] Tel.: +41 (0) 21 653 0200. EU Media Contact. Alexandre Müller.

Category: Contact NumberShow more

Adcentrx Therapeutics Inc Protein Conjugate Therapeutic

1 hours ago Adcentrx.com Show details

Adcentrx Therapeutics Closes $50 Million Series A Financing Round. Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule

Category: Contact NumberShow more

Protocol Number: ADCT301001 Official Title: A Phase 1

7 hours ago Clinicaltrials.gov Show details

EudraCT Number: 2015‐005272 ‐25 A Phase 1 Adaptive Dose -Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, an d Antitumor Activity of ADCT -301 in Patients w ith Relapsed or Refractory Hodgkin Lymphoma and Non -Hodgkin Lymphoma . PROTOCOL NO. : ADCT- 301- 001. Sponsor: ADC Therapeutics SA . Sponsor Contact:

Category: Contact NumberShow more

ADC Therapeutics Employees, Board Members, Advisors & Alumni

3 hours ago Crunchbase.com Show details

Number of Employee Profiles 15. ADC Therapeutics has 15 current employee profiles, including CEO Christopher Martin. Christopher Martin CEO. Liangyi Zhang Associate Director, CMC Analytical. Michael Forer Vice Chairman and Executive Vice President. Jens Würthner Head of Clinical Development – EU. Jay Feingold Senior Vice President, Chief

Category: Contact NumberShow more

ADC Therapeutics LinkedIn

8 hours ago Uk.linkedin.com Show details

ADC Therapeutics 6,638 followers on LinkedIn. Innovating Science. Inspiring Hope. ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology. These proprietary PBD-based ADCs are expected to …

Category: Contact NumberShow more

ADC Therapeutics to Move Antibody Drug Conjugate ADCT401

3 hours ago Ir.adctherapeutics.com Show details

19 May 2014 Lausanne, Switzerland and London, UK, May 19 2014 – ADC Therapeutics (ADCT), an oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, announced today that it has selected its first IND candidate under its joint development agreement with MedImmune, the global …

Category: Contact NumberShow more

ADC Therapeutics SA Number of Employees 20192021 ADCT

6 hours ago Macrotrends.net Show details

ADC Therapeutics SA number of employees from 2019 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

ADC Therapeutics Expands Team – ADC Therapeutics

5 hours ago Ir.adctherapeutics.com Show details

30 September 2014 Lausanne, Switzerland and London, UK, 30 September, 2014 – ADC Therapeutics (ADCT, a portfolio company of Auven Therapeutics) the oncology drug development company focused on Antibody Drug Conjugates (ADCs) targeting major cancers, today announced a significant expansion of its team as the Company’s first ADCs enter clinical development.

Category: Contact NumberShow more

Synaffix and ADC Therapeutics Expand ADC Review

6 hours ago Adcreview.com Show details

The company has become partner for a number of ADC developers around the world. ADC Thereapeutics is a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent and targeted antibody-drug conjugates (ADCs) for patients with hematological malignancies and solid tumors.

Category: Contact NumberShow more

Press Releases – ADC Therapeutics

8 hours ago Ir.adctherapeutics.com Show details

ADC Therapeutics Announces Presentations at the 2021 ASCO Annual Meeting. May 17, 2021. ADC Therapeutics Announces Receipt of $50 Million Second Tranche of Convertible Credit Facility with Deerfield. May 12, 2021. ADC Therapeutics Announces Online Publication of LOTIS-2 Results in The Lancet Oncology. May 06, 2021.

Category: Contact NumberShow more

ADC Therapeutics Funding, Financials, Valuation & Investors

5 hours ago Crunchbase.com Show details

ADC Therapeutics has raised a total of $691.6M in funding over 9 rounds. Their latest funding was raised on May 17, 2021 from a Post-IPO Debt round. ADC Therapeutics is registered under the ticker NYSE:ADCT . Their stock opened with $19.00 in its May 14, 2020 IPO. ADC Therapeutics

Category: Contact NumberShow more

Jack Khattar Chairman, Board of Directors Cognition

8 hours ago Linkedin.com Show details

About. Has more than 30 years of industry experience in the development and commercialization of pharmaceutical products and drug delivery technologies. Prior to founding Supernus in 2005 and for

Title: President and CEO, Supernus …
Location: Gaithersburg, Maryland, United States
1. 500+ connections

Category: Contact NumberShow more

How a CDMO can Support ADC Manufacturing » ADC Review

6 hours ago Adcreview.com Show details

Innovation In the development of life-saving drugs, such as ADCs, innovation and speed-to-market are critical. [1] Focusing on their own competencies and improving efficiency, pharmaceutical companies are also consolidating their supplier base, selecting strong partners from a small number of CDMOs that offer dedicated services across a number of novel investigational drugs as well as

Category: Support NumberShow more

ADC Therapeutics Announces Medical Leadership Transition

1 hours ago Finance.yahoo.com Show details

LAUSANNE, Switzerland, September 03, 2021--ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of those affected by cancer with its …

Category: Contact NumberShow more

The top 10 antibody drug conjugate contenders in 2021

Just Now Fiercepharma.com Show details

Mersana Therapeutics. 8. AbbVie. 9. ImmunoGen. 10. Sanofi. Book traversal links for The top 10 antibody drug conjugate contenders in 2021. 1.

Category: Contact NumberShow more

ADC Therapeutics (NYSE:ADCT) Downgraded by Zacks

4 hours ago Marketbeat.com Show details

ADC Therapeutics SA is based in LAUSANNE, Switzerland. "A number of other research analysts have also issued reports on the stock. Cantor Fitzgerald initiated coverage on shares of ADC Therapeutics in a research note on Tuesday, June 15th. They set an "overweight" rating and a $46.00 target price for the company.

Category: Contact NumberShow more

Mersana Therapeutics Presents Preclinical Data

2 hours ago Finance.yahoo.com Show details

CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a …

Category: Contact NumberShow more

ADC Therapeutics SA Sample Contracts Law Insider

2 hours ago Lawinsider.com Show details

ADC Therapeutics SA – Collaboration and License Agreement between ADC Therapeutics Sarl and Genmab A/S. This Collaboration and License Agreement (“Agreement”) is made and entered into, effective as of 14 June 2013 (“Effective Date”), by and between ADC Therapeutics Sarl, a Swiss corporation, having its head office at Rue Saint-Pierre 2, Lausanne, 1003, Switzerland (“ADCT”), and

Category: Contact NumberShow more

ADC Therapeutics SA (ADCT) Is Another Fantastic Bargain

1 hours ago Marketingsentinel.com Show details

ADC Therapeutics SA (NYSE:ADCT)’s Major holders. Insiders own 48.05% of the company shares, while shares held by institutions stand at 43.36% with a share float percentage of 83.47%. Investors are also buoyed by the number of investors in a company, with ADC Therapeutics SA having a total of 71 institutions that hold shares in the company.

Category: Contact NumberShow more

Michael Forer Vice Chairman and Executive Vice President

7 hours ago Crunchbase.com Show details

Michael Forer serves as Vice Chairman and Executive Vice President at ADC Therapeutics;he is also Partner, European Origination for Auven Therapeutics. Prior to joining ADC Therapeutics and Auven, Mr. Forer co-founded Rosetta Capital Limited (Rosetta), a London-based advisory and private equity firm focused on the life science sector.

Category: Contact NumberShow more

Annette ErvinHaynes at ADC Therapeutics AroundDeal

7 hours ago Arounddeal.com Show details

Vice President -Head of Early Drug Development at ADC Therapeutics. Annette Ervin-Haynes is the Vice President -Head of Early Drug Development at ADC Therapeutics based in United States.Established pharmaceutical R&D physician with experience in global pharmaceutical companies. Impact on multiple therapeutic areas within hematology and oncology.

Category: Contact NumberShow more

Jens Wuerthner at ADC Therapeutics AroundDeal B2B

1 hours ago Arounddeal.com Show details

Vice President, Head of Global Clinical Development Oncology at ADC Therapeutics. Jens Wuerthner is the Vice President, Head of Global Clinical Development Oncology at ADC Therapeutics based in Switzerland.Physician with >20 years of clinical and research experience in oncology & immunology/infectious diseases as a team leader in academia, big pharma and biotech.

Category: Contact NumberShow more

Antibody Drug Conjugates Industry Insights, 20192030

9 hours ago Globenewswire.com Show details

917-300-0470

Contact Data CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For

Category: Contact NumberShow more

Featured Lab – ADC Therapeutics Labguru

8 hours ago Labguru.com Show details

ADC Therapeutics was founded in 2012, and we have raised $455 million since that time to advance our pipeline of programs. We are based in Lausanne, Switzerland and have operations in London (R&D), New Jersey (Clinical) and San Francisco (CMC). The team at ADCT has a deep understanding of ADCs and the oncology treatment landscape.

Category: Contact NumberShow more

Paulann Buczek (Firmender) Associate Director, Access

Just Now Linkedin.com Show details

Access Communications LLC. Jan 2012 - Feb 20131 year 2 months. NJ. Served as Group Account Supervisor across multiple books of Managed Markets business. Experienced in the …

Title: Associate Director, Access …
Location: New York City Metropolitan
1. 500+ connections

Category: Contact NumberShow more

Simon Chivers at ADC Therapeutics AroundDeal B2B

Just Now Arounddeal.com Show details

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology. These proprietary PBD-based ADCs are expected to provide a novel way to treat hematological cancers and

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is adc therapeutics inc?

ADC Therapeutics (NYSE: ADCT) is a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation, targeted antibody drug conjugates (ADCs). The Company is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

What are the goals of adcentrx therapeutics inc?

By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.

How are adc drugs used in the production process?

In order to overcome the ADC drugs that produce various DARs in the production process, some studies have adopted innovative methods of site-specific conjugating to reduce variability, improve conjugating stability and pharmacokinetic properties, and ultimately produce more ADC drugs. 2. Action Mechanism of ADCs

What are the parameters for selecting an adc?

The basic parameters for selecting an effective toxic payload for the ADC include conjugating, solubility, and stability. The structure of the selected toxic molecule should be such that it can be coupled to a linker.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Amgen
Att
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes